Semi-Annual Consolidated Balance Sheet

Modalis Therapeutics Corporation - Filing #7312187

Concept As at
2024-06-30
As at
2023-12-31
Semi-annual consolidated balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
1,278,281,000 JPY
1,883,437,000 JPY
Other
50,741,000 JPY
66,533,000 JPY
Current assets
1,332,510,000 JPY
1,956,323,000 JPY
Non-current assets
Investments and other assets
77,165,000 JPY
69,601,000 JPY
Investments and other assets
Non-current assets
77,165,000 JPY
69,601,000 JPY
Assets
1,409,675,000 JPY
2,025,925,000 JPY
Liabilities
Current liabilities
Income taxes payable
5,510,000 JPY
5,973,000 JPY
Other
88,701,000 JPY
192,128,000 JPY
Current liabilities
103,239,000 JPY
198,101,000 JPY
Non-current liabilities
Other
28,412,000 JPY
30,577,000 JPY
Non-current liabilities
193,708,000 JPY
447,401,000 JPY
Bonds with share acquisition rights
162,500,000 JPY
412,500,000 JPY
Liabilities
296,948,000 JPY
645,502,000 JPY
Provision for bonuses
9,026,000 JPY
JPY
Net assets
Share capital
273,583,000 JPY
1,217,652,000 JPY
Shareholders' equity
Capital surplus
1,595,318,000 JPY
2,539,387,000 JPY
Retained earnings
-788,671,000 JPY
-2,410,273,000 JPY
Treasury shares
-97,000 JPY
-97,000 JPY
Shareholders' equity
1,080,132,000 JPY
1,346,669,000 JPY
Valuation and translation adjustments
Foreign currency translation adjustment
16,124,000 JPY
7,323,000 JPY
Valuation and translation adjustments
16,124,000 JPY
7,323,000 JPY
Share acquisition rights
16,470,000 JPY
26,430,000 JPY
Net assets
1,112,727,000 JPY
1,380,422,000 JPY
Liabilities and net assets
1,409,675,000 JPY
2,025,925,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.